Gastric Bypass in Turin Italy
This surgery also called Bariatric Surgery , "baros" meaning weight from Greek. The idea behind this procedure is to create a smaller stomach so most of the food will bypass the stomach and only a small proportion will eventually end up entering your body. Smaller stomach volume will cause you to eat less because you'll feel full earlier and fewer calories will be absorbed. The surgery also creates a bypass to some part of the small intestine, which also contributes to less absorption. This results in weight loss. This surgery usually performed on people who have body mass index above 40 or those who have serious comorbidities resulting from their weight. Sometimes the doctors also recommend this surgery for people who haven't succeeded in losing weight with alternative methods. Some other conditions, which are considered, are: not having alcohol abuse or psychiatric disorder such as depression and you should also be between the ages of 18-65. In general most of the clinics require candidates with long term commitment to change life habits like training and diet.
This operation can be performed using several techniques, the most common one called Roux-en-Y gastric bypass. In a normal digestion process the food passes from the stomach to the small intestine and then to the large intestine. In the small intestine most of the nutrients are absorbed. To create a bypass the surgeon will create a small pocket in the upper portion of the stomach using a special plastic ring or staples. Then he'll connect the "new" stomach to the middle portion of the small intestine called jejunum, that way the food will bypass the rest of the stomach and upper portion of the small intestine called duodenum.
The surgery can be performed by making a large cut on the abdomen (laparotomy) or by making few small cuts with minimally invasive technique (laparoscopy).
Common risks for this procedure include infection, peritonitis, pulmonary embolism, gallstones and nutrients deficiency such as B12, iron and calcium.
After the surgery you'll have to stay in hospital for 4-6 days after laparotomy and 2-3 days after laparoscopy. Most of the people are able to return to their daily activities after 3-5 weeks.
You'll need to drastically change your eating habits, you should eat small amount of food more often. This will help to minimize "dumping syndrome" which is due to food moves too quickly from the stomach to the intestine and may cause sweating, weakness and dizziness.
More Turin info...
Turin By train
Turin has two main railway station, Porta Nuova and Porta Susa. There also a smaller station near Lingotto area.
Generally speaking, Porta Nuova is a station dedicated to mid-range and long-range trains. Porta Susa serves some local trains, but the trains for Milan - leaving from Porta Nuova - also transit there. You'd better check in advance where you need to go. Many trains also stops in both stations.
Both stations are managed by Trenitalia, the Italian state railways.
-
Turin Mid-range
L Birichin, Via Vincenzo Monti 16/a, 011 65 74 57, [8]]. $35-$45.
Arcadia, Galleria Subalpina (Piazza Castello), 011 56 13 898 beautiful place, sushi bar.
Trattoria Ala, Via Santa Giulia 24, 011 81 74 778. For about 35$ you will get delicious food and wine. Definitely to try Cantucci con vinsanto dessert. Beware that they cook Tuscany-typical food, so if you are looking for Piedmon-typical food, you may not be in the very right place. -
Gastric BypassLatest Forum Posts...
- My brother is thinking of undergoing gastric bypass surgery. He really needs to do something about his weight. I have heard though that there are medical conditions wherein people are just predisposed to becoming obese. If my brother is, since a lot of our family members (even aunts and my granpda) are overweight, will gastric bypass surgery solve his problem or is it just a waste of money?
Plastic Surgery News...
- Liver transplant is a life saving treatment option for people with end-stage liver disease. Unfortunately, the need for donor livers far exceeds the supply. Each year only about one-third of people who need a donor liver will receive one, and some patients die while waiting.
- The FDA has issued an early communication about recent findings of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study, which indicated a higher risk of heart attack in HIV patients on abacavir (Ziagen®) or didanosine (Videx®). The study is a large international observational study of 33,347 patients who are being followed to evaluate the short and long term adverse effects of treatment with HIV drugs. Analyses of data collected through February 1, 2007 examined the risk of heart attack in patients taking nucleoside reverse transcriptase inhibitors and found that there was an increased risk of heart attack by 49% in patients taking didanosine and by 90% in patients taking abacavir. The risk did not appear to increase over time, but remained stable and appeared to be reversible after the drugs were stopped. The risk appeared to be greater in patients with other risk factors for heart disease. The agency will continue to evaluate the overall risks and benefits of these two drugs to ascertain if there is a need to revise their product labelling. Until the FDA’s review is complete, health care professionals should evaluate the potential risks and benefits of each antiretroviral drug taken by their patients.